drugset / Trial / NCT05977140
CDI-988 Safety Study in Healthy Participants
Phase 1
Completed
116 enrolled
Cocrystal Pharma, Inc.
Beyond Drug Development Pty Ltd. · collabCocrystal Pharma Australia Pty Ltd. · collabResolutum Global Pty Ltd. · collabScientia Clinical Research Pty Ltd · collab
RandomizedSequentialQuadruple-blindTreatment
Summary
The goal of this clinical trial is to learn about the safety and pharmacokinetics (PK, the amount of drug in the blood) of a new drug called CDI-988 in healthy volunteers. The main questions it aims to answer are: * Are there any side effects of the drug? * What is the amount of drug that reaches the bloodstream? Participants will be assigned by chance to take either CDI-988 or placebo by mouth and have physical exams, electrocardiograms (ECGs), vital signs, and blood tests to look for any side effects.
Timeline
- Start
- 2023-09-27
- Primary completion
- 2025-05-23
- Completion
- 2025-07-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CDI-988 | Unknown | — | Oral |
Indications
No indication recorded.